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1. Introduction 
Stem cells (SCs) are undifferentiated cells which are able to remain at this state for several 
generations following cell proliferations. SCs are also able to take part in natural in vivo 
phenomena such as wound repair after physical damages or tissue regenerations.  
On this basis, endometrial stem cells (EnSCs), characterized by higher abilities for 
proliferation, differentiation, fast angiogenesis during menstruation and immune tolerance 
for embryo during pregnancy, have been considered as a valuable source of stem cells 
(Gargett, Chan et al. 2007; Meng, Ichim et al. 2007). Several researches have demonstrated 
presence of highly pleuripotent mesenchymal stem cells in endometrium by differentiation 
potency to various cell types such as, insulin producer cells (Li, Chen et al. 2010), osteoblasts 
(Ai, Mehrabani. 2010) , odontoblasts (Ai, Tabatabaei et al. 2009), neurons (Wolff, Gao et al. 
2011) (Ai, Tabatabaei et al. 2009) and Myoblast (Ai, Tabatabaei et al. 2009). These findings 
may open up new opportunities to use endometrial stem cells in tissue engineering and cell 
therapy (Ai , Mehrabani. 2009). 
Additionally our previous studies demonstrated that EnSCs are able to participate at a 
phenomenon like angiogenesis in 3-D cultures which is similar to early stages of 
endometriosis (Esfandiari, Ai et al. 2007; Esfandiari, Khazaei et al. 2007;  Esfandiari, Ai et al. 
2008) which may propose a novel mechanism in pathogenesis of endometriosis compared to 
the traditional theory that emphasis on retrograde menstruation as a possible factor. These 
studies are supported by others who demonstrated recruitment of bone marrow-derived 
mesenchymal stem cells to the endometrium (Taylor 2004) and these all may point to the 
role of stem cells at the pathogenesis of endometriosis (Figueira, Abrão et al.; Sasson and 
Taylor 2008). Therefore, endometrial stem cells could be considered as binary role-player in 
natural function of endometrium and endometriosis and potentially could be used as a 
target in endometriosis therapy. 
2. Histology of human uterus 
The inner layer of uterus (Endometrium) comprises the mucosal lining which is highly 
regenerative tissue during menstrual cycle. The human endometrium undergoes more than 
400 cycles of shedding and regeneration during a woman's reproductive years (McLennan 
and Rydell 1965). This layer is backed by a thick muscular myometrium which consists of 
muscular cells. There is no submucosal tissue to separate endometrial glandular tissue from 
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underlying smooth muscle. The endometrium is composed of single columnar epithelial 
layer, resting on a layer of connective tissue, the stroma. Tubular glands reach through the 
endometrial surface to the base of stroma. In a woman of reproductive age, the 
endometrium itself is structurally and functionally divided into two relatively distinct layers 
of upper functionalis and lower basalis. The functionalis zone is adjacent to uterine cavity 
and contains glands and supportive stroma for optimal implantation and growth condition 
of embryo. Basalis (basal layer), adjacent to myometrium, provides basal region of glands, 
dense stroma and lymphoid aggregates and from it functional layer develops. During 
menstrual cycle only the functional layer is regenerated and the basal layer is not affected. 
Both endometrium and subendometrial myometrium originate from the Müllerian ducts 
during embryonic life. However, outer myometrial layer is formed during fetal life and from 
non- Müllerian origin (Ferenczy and Bergeron 1991).  
The cellular components of human endometrium can be primarily divided into two cell 
types; the epithelial cells (luminal and glandular) and the supporting mesenchymal cells 
(stromal cells) as well as vascular (endothelial) cells and leukocytes.  
3. Endometriosis  
It is acknowledged that about 11% of all women population during reproductive age is 
affected by endometriosis (Buck Louis, Hediger et al. 2011). Endometriosis is a chronic 
benign gynecological disease which is characterized by the ectopic formation of endometrial 
stroma and glands mostly seen in pelvic peritoneum. However, it might be seen outside the 
pelvic peritoneum such as, pelvic viscera(Vercellini, Meschia et al. 1996), rectovaginal 
septum (Nisolle and Donnez 1997), pleura, abdominal wall, and even sometime in brain 
(Thibodeau, Prioleau et al. 1987). Briefly, the underlay mechanism is attachment of 
endometrial cells to the pelvic peritoneum, invasion into the mesothelium, and survival and 
proliferation of the ectopic endometrial cells. Endometriosis is usually diagnosed after 
symptoms such as pelvic pain, which might correlate with menstrual cycle, or infertility.  
4. Etiology and pathophysiology of endometriosis 
The source of endometrial implants is not fully understood. However, there are evidences 
for competence of some women over others (Di and Guo 2007). The reasons for 
susceptibility of some patients for development of ectopic lesions are not clear. Comparative 
microarray analysis of gene expression in patients with ectopic endometrial cells and that of 
eutopic endometrium has demonstrated an alternative pattern of gene expression in two 
groups (Taylor, Lundeen et al. 2002; Giudice 2003; Giudice 2006). This is also seen between 
patient and non-affected women (Gogusev, de Joliniere et al. 1999; Taylor, Lundeen et al. 
2002; Giudice 2003; Giudice 2006; Wu, Strawn et al. 2006).  
Although etiology of disease has not been clearly understood, a number of theories have 
been proposed in correlation with the pathogenesis of endometriosis which includes: genetic 
and environmental factors, immune system, retrograde menstruation, coelomic metaplasia, 
embryonic rest theory, lymphovascular metastasis and stem cell-based theory. Clinical 
manifestation of endometriosis and ectopic formation of endometriotic lesions usually 
considered as end point result of several aberrant biological process. 
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5. Stem cell-based theory 
5.1 Stem cells  
Stem cells are undifferentiated cells which are defined by their functional properties such as; 
high proliferative potential, substantial self-renewal capacity and ability to differentiate to 
other organ/tissue-specific cell types. Cellular self- renewal is a capacity that parental stem 
cells are able to divide into two daughter cells which can happen through symmetrical or 
asymmetrical division. The symmetrical division produces two identical daughter stem cells 
or transit amplifying (TA) cells. TA cells undergo repetitive cell division cycles and 
progressively acquire differentiation marker and lose their self-renewal capacity. 
Asymmetrical division leads to an identical daughter cell as well as a more differentiated 
cell.   
Although stem cells are potentially capable to proliferation, they remain mostly in a 
quiescent state until an inductive factor to induce them to proliferation. 
Adult stem cells present in all organs and tissues and are responsible for tissue regeneration 
and repair after damage and trauma encountered during life time.  
Rarity and lack of distinguishable morphological features and specific molecular markers of 
stem cells have  hindered their isolation, purification and studies for several years.   
Broadly they can be divided into two categories, embryonic and adult stem cells. Stem cells 
can also be divided into various groups according to their differentiation capacity. For 
example, the zygote can be considered as a totipotent stem cell, which means it is able to 
differentiate into all other cell types in embryo and extraembryonic tissue. Other stem cells 
with decreased levels of potency can be named as; pluripotent, which can differentiate into 
nearly all cell types (e.g., inner cell mass of the blastocyst), multipotent, which can 
differentiate into a number of cells that are closely related family of cell (e.g., Hematopoetic 
stem cells), oligopotent which differentiate into a few cell types (e.g., myeloid or lymphoid 
stem cells) and unipotent, which differentiate into only one cell type with self-renewal 
capacity(e.g., muscle stem cell ).  
Anatomic structure surrounding stem cells which have profound effect on cell function is 
called niche. Signaling elements and various cellular and molecular interactions inside the 
niche can determine the fate of cell to stay in undifferentiated state until tissue regeneration 
or repair to motivate stem cell differentiation.    
5.2 Evidences for existence of endometrial stem cells  
5.2.1 Indirect evidences 
Adult stem cells present throughout whole body and responsible for replenishment and 
regeneration of damaged tissues and contribute to the structural and functional 
maintenance of tissues and organs. Human endometrium undergoes periodical process of 
regeneration during menstrual cycle. The growth rate may vary between 0.5 -7mm in 
thickness. Menstruation is a phenomenon consisted of various cellular and tissue functions 
from cell proliferation and differentiation to shedding and regeneration. During each 
menstrual cycle, the functionalis and a part of basalis layer of endometrium undergo 
shedding. After shedding, the endometrium regrows under the influence of estrogen. 
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Regeneration process is comprised of endometrial regrowth, angiogenesis and proliferation 
of endometrial stromal cells. Shedding and regeneration of the endometrial layer during 
menstruation and regeneration of functional layer may be considered as an indirect 
evidence for presence of progenitor/ stem cells. This concept was proposed in 1978 by 
Prianishnikov (Prianishnikov 1978), and then confirmed by following clinical observations 
(Wood and Rogers 1993), proliferation experiments and demonstration of gland 
monoclonality (Tanaka, Kyo et al. 2003; Chan, Schwab et al. 2004; Schwab, Chan et al. 2005). 
In some other species this process is carried out in the form of endometrial growth and 
apoptosis rather than menstrual cycle. Therefore, this is conceivable that endometrium 
consists of an active and regenerative population of cells which are known as endometrial 
progenitor/stem cells (EnSCs). Since endometrium  consists of glands, surface epithelium 
and supportive stroma, the existence of both epithelial and stromal stem/progenitor cells 
are plausible. 
5.3 Evidence from cell cloning studies 
The first reports for the existence of EnSCs on human endometrium came from clonogenic 
studies which identified epithelial and stromal stem cells (Tanaka, Kyo et al. 2003).  By study 
carried out later on purified single cell suspensions obtained from hysterectomy tissue, 
0.22±0.07% of endometrial epithelial cells and 1.25±0.18% of stromal cells formed individual 
colonies within 15 days (Chan, Schwab et al. 2004). Although both were clonogenic, the 
stromal stem cells were significantly more clonogenic than epithelial stem cells, and small 
and large colonies were observed in two types. The number of large colonies was lower than 
the smaller (0.09% of epithelial cells and 0.02% of stromal cells) and it may be hypothesized 
that they belong to stem cells population which are rare among other more mature transit 
amplifying cells. These colonies displayed significantly greater self-renewal capacity 
compared with the small and loose colonies. This observation lead to the hypothesis that 
larger colonies belong to endometrial stem/progenitor cells, and the smaller belong to 
transit amplifying (TA) cells with greater extent of differentiation. 
The presence of clonogenic stromal and epithelial cells are also reported in inactive, 
noncycling endometrium (Schwab, Chan et al. 2005). This study showed similar frequency 
of clonogenicity for epithelial and stromal cells in different phases of the menstrual cycle or 
in inactive endometrium. These data further point to the presence of endometrial 
stem/progenitor cells within basalis layer in higher number than the functionalis layer.  
5.4 Side population cells 
Side population (SP) cells are a small fraction of cells within tissues with dye-effluxing 
properties. They are detected by flowcytometric analysis of pre-incubated cells with DNA-
binding dye, Hoechst 33342. This is due to the expression of ABCG2, a plasma membrane 
transporter.  SP cells have been identified from various adult tissues, demonstrating that this 
phenotype may represent a common feature of adult stem cells. SP cells were identified in 
short-term culture of two fractions filtered from human endometrial cell suspension (Kato, 
Yoshimoto et al. 2007). Upper fraction comprised mainly of epithelial (CD9+) cells and the 
lower fraction contained both epithelial and stromal (CD13+) cells. Further differentiation 
studies on Matrigel demonstrated the capacity of epithelial side population to differentiate 
into gland-like structures expressing CD9 and E-cadherin. On the side, cell differentiation 
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study of lower fraction showed the capacity to differentiate into CD13+ stromal-like clusters. 
Additionally, to test whether endometrial SP cells reconstitute the endometrial tissue with 
stromal and glandular structure, they were xenotransplanted into NOG mice (Maruyama 
2010). These studies not only demonstrated the presence of endometrial stem/progenitor 
cells, they have also provided an experimental animal model for endometriosis which is 
valuable in endometriosis studies. 
5.5 Evidence from mouse 
Mouse could be used as an experimental model for endometriosis and endometrial stem cell 
studies. However, the structure and physiology of mouse endometrium is not exactly 
similar to that of human. The mouse lacks an endometrial basalies layer, and the 
endometrium does not shed during menstruation but rather it is reabsorbed after the cycle. 
In spite of these dissimilarities, the murine estrous cycle has characteristics similar to those 
of human menstrual cycle and then mouse uterus can provide data on the molecular and 
cellular information for the pathogenesis of endometriosis and normal activity of 
endometrium tissue. 
On this basis, several studies have been conducted to demonstrate the presence of 
endometrial stem cells in mouse endometrium (Cervello, Martinez-Conejero et al. 2006; 
Chan and Gargett 2006). For example, label-retaining cells (LRCs) have been shown in the 
mouse uterus.  Label retaining is a technique to identify a stem cell population in vivo on the 
basis of quiescent state of stem/progenitor cells. The cells in this state are able to retain 
DNA strand incorporated stains such as, 5-bromo-2´-deoxyuridine (BrdU) for a longer 
period than the active dividing cells. A study conducted by Chan and Gargett showed that 
3% of mouse endometrial epithelium after a 56-day chase period and 6% of endometrial 
stromal cells after an 84-day chase period are LRCs. Also, in another study Cevello et al 
demonstrated that 9% of stromal cells after 49 days were LRCs and this decreased to 1.7% 
after 112-day chase period. However, no epithelial LRCs were identified even after 21 days 
(Cervello, Martinez-Conejero et al. 2006). Presence of LRCs have also been demonstrated in 
myometrium (Szotek, Chang et al. 2007).   
5.6 Endometrial regenerative cells (ERCs) from menstrual blood 
Endometrial stem/progenitor cells have also been obtained from menstrual blood. These 
cells can be maintained in culture for more than 68 doubling and during this time they are 
able to retain their  markers such as CD9, CD29, CD41a, CD44, CD59, CD73, CD90 and 
CD105 without karyotypic abnormalities (Musina, Belyavski et al. 2008). Proliferative rate of 
these cells are also significantly more than mesenchymal stem cells from the source of 
umbilical cord. 
Endometrial regenerative cells (EnRCs) from menstrual blood are different from 
endometrial stem cells at expression of STRO-1. These cells are also negative for 
hematopoetic markers such as, CD34, CD45, CD133, but express embryonic stem cell 
marker, Oct4. 
Ease of collection could be considered as an important characteristic of EnRCs which make 
them more attractive. Karyotypic stability of EnRCs suggests a large scale expansion 
capability.  
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5.7 Endometrial cancer stem cells  
Presence of specific type of stem cells called cancer stem cells have been pointed at recent 
years (Bomken, Fišer et al. 2010). Cancer stem cell refers to a subset of tumour cells which 
are able to self-renew and generate the diverse cells in tumour cell mass. In fact, many 
features of carcinoma can be explained by the stem cell concept, including clonal origin and 
heterogeneity of tumors, the mesenchymal influence on cancer behavior, the local formation 
of precancerous lesions and the plasticity of tumor cells (Miller, Lavker et al. 2005). 
A gold standard to evaluate the presence of cancer stem cells is to check their 
tumorogenicity on immunocompromised mice following serial transplantation. It is now 
postulated that cancer stem cells are responsible for cancer return after current cancer 
therapies e.g., radio- or chemotherapy. Recently, presence of endometrial cancer stem cells 
among endometrial carcinoma cells has been reported (Hubbard, Friel et al. 2009).  
5.8 Signalling pathways involved in EnSCs’ biology      
Evidences from early studies of human EnSCs revealed the influences of three growth 
factors on clonogenisity of both epithelial and stromal cells. These are platelet-derived 
growth factor-BB (PDGF-BB), transforming growth factor-α (TGF-α) and epithelial growth 
factor (EGF). Basic fibroblast growth factor (b-FGF) was also able to induce clonogenicity on 
stromal stem cells but was not effective on epithelial cells. This could point to the difference 
of two cell types in expression of cognate receptor and this may propose two relatively 
distinct niches for them.      
Also in serum-free culture condition, epithelial cells are relying on fibroblast feeder layer for 
clonogenicity. This may emphasis on the importance of epithelial-stromal interactions. 
5.9 Endometrial stem cell markers   
No specific marker has been identified for endometrial progenitor stem cells. This may 
hinder the isolation of EnSCs from surrounding cells utilizing the techniques such as FACS 
and MACS. Instead, a technique called label-retaining cell (LRC) have been successfully 
utilized to identify progenitor/stem cells among others in vivo.  
Oct-4 is a transcription factor which is crucial for the maintenance of cell pluripotency and is 
known to be expressed in embryonic stem cells, germ cells, whole embryos at various stages 
of development and adult stem cells. It is also reported in almost half of the endometrial 
samples (Matthai, Horvat et al. 2006). Expression of Oct4 mRNA has been detected in all 
endometrial samples of 89 women in follicular or luteal phase of menstrual cycle (Bentz, 
Kenning et al. 2010).  
Expression of other general stem cell markers such as bcl-2, c-kit (CD117) and CD34 have 
also been reported on endometrial stem cells (Cho, Park et al. 2004).   Haematopoietic stem 
cell markers (CD34 and CD45) that co-express CD7 and CD56 have also been identified in 
human endometrial cell suspension that may belong to lymphoid progenitors. 
Expression and localization of Musashi-1, a RNA-binding protein, have been evaluated in 
endometrial, endometriotic and endometrial carcinoma tissue specimens (Götte, Wolf et al. 
2008). Musashi-1 is an epithelial progenitor cell marker. It is expressed on endometrial 
glandular and stromal cells and in proliferative endometrium. The proportion of Musashi-1-
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positive cells in the basalis layer significantly increase in the stroma (1.5 fold) and in 
endometrial glands (three fold) compared to functionalis. Musashi-1 is also expressed in 
high levels in endometriosis and endometrial carcinoma (Götte, Wolf et al. 2008).  
5.10 Differentiation ability of endometrial stem cells 
Differentiation potency of endometrial stem cells has been demonstrated in several studies, 
suggesting their potency to be used as a useful source in cell therapy and tissue engineering.   
Kato et al used two markers of CD9 and CD13 to show that side population cells can 
differentiate into endometrial epithelial and stromal cells respectively(Kato, Yoshimoto et al. 
2007).  
Additionally, endometrial stromal cells have the potency to differentiate into chondrocytes 
when cultured in a defined chondrocyte medium. Also, large putative stromal 
stem/progenitor cell colonies consist of multipotency by differentiation into mesenchymal 
lineages-adipocytes, smooth muscle cells, chondrocytes and osteoblasts when cultured in an 
appropriate differentiation medium. By contrast, the small, loose colonies failed to 
demonstrate similar differentiation capacity that may suggest these cells are derived from 
TA cells. 
Endometrial regenerative cells from menstrual blood are also able to differentiate to various 
cell lineages such as, insulin producer cells ( Li, Chen et al. 2010), osteoblast ( Ai, Mehrabani. 
2010) , odontoblasts (Ai, Tabatabaei et al. 2009), and neurons ( Wolff, Gao et al. 2011  and Ai, 
Esfandiari et al. 2009a). 
EnSCs have been recently used to replace dopaminergic neurons in a murine model of 
Parkinson's disease (Wolff, Gao et al. 2011). Cardiogenic potential of EnSCs have also been 
high-lighted by several studies (Hida, Nishiyama et al. 2008).  
5.11 Endometrial regeneration and angiogenesis 
Endometrium is well known for its profound angiogenic potency which may point to the 
presence of a highly regenerative back-up layer (Esfandiari, Ai et al. 2007; Esfandiari, 
Khazaei et al. 2007; Esfandiari, Ai et al. 2008 and  Ai, Esfandiari et al 2009a and 2009b). 
Angiogenesis plays a pivotal role in endometrium regeneration during menstrual cycle. It is 
also involved in establishment and development of endometriosis lesions (Donnez, Smoes et 
al. 1998; Fujishita, Hasuo et al. 2000).  
5.12 Sources of endometrial stem/progenitor cells 
5.12.1 Fetal stem cells  
It is thought that some embryonic cells in the intermediate mesoderm undergo 
mesenchymal to epithelial transitions to form the coelomic epithelium that later invaginates 
to make the paramesonphric or Murrelian ducts (Kobayashi and Behringer 2003). Müllerian 
ducts comprise of surface epithelium and underlying urogenital ridge mesenchyme which 
are the source of endometrium and myometrium. A few epithelial and mesenchymal cells 
are thought to remain in the adult endometrium and contribute to tissue regeneration 
during menstrual cycle. This small population of stem cells might be subdivided into 
epithelial and stromal or even more committed sub-lineages or might exist in the form of 
ultimate uterine stem cells with a capacity to replace all endometrial and myometrial cells. 
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5.13 Bone marrow-derived stem cells as a possible source of endometrial 
progenitor/stem cells   
Interestingly, regenerative turnover in endometrium is equivalent to that in bone marrow 
(Fuchs and Segre 2000).  Bone marrow is commonly known as a source of hematopoetic and 
non-hematopoetic stem cells. Hematopoetic stem cells are mainly involved in the 
homeostasis of cellular part of blood. However, non-hematopoetic stem cells can 
differentiate into various cell types, e.g., endothelial cells, hepatocytes, neurons, skin, 
cardiomyocyte, gastrointestinal epithelium (Alison, Poulsom et al. 2000; Mezey, Key et al. 
2003; Taylor 2004), suggesting their possible contribution to the maintenance of multiple 
tissues. 
Apart from fetal source of stem cells resideing in adult endometrium which is speculated to 
account for the endometrium replacement after each menstrual cycle, new observations 
support the role of bone marrow-derived stem cells at endometrial regeneration. 
Migration and presence of donor-derived bone marrow cell to/in endometrium and 
generation of experimental endometriosis have been reported after murine bone marrow 
transplantation (Taylor 2004; Du and Taylor 2007). Also, presence of chimerism in the 
endometrial glands and stroma of four women who received single-antigen HLA-
mismatched bone marrow transplants can point to the contribution of bone marrow stem 
cells to the repopulation of the endometrium (Taylor 2004). Bone marrow-derived cells are 
indistinguishable from endogenous endometrial cells and express glandular and stromal 
differentiation markers.  
Whether bone marrow-derived stem cells are involved in the normal function and 
regeneration of endometrium or pathogenesis of endometriosis is not clear. However, this 
theory is appropriately able to explain ectopic endometriosis. 
5.14 Stem cell-based theory of endometriosis 
Today, a combination theory is more acceptable for the pathogenesis of endometriosis. 
Evidences for existence of pluripotent endometrial stem cells, and contribution of bone 
marrow as an alternative source of EnSCs as well as the direct correlation of endometriosis 
and menstrual retrograde have convinced researchers to propose that stem/progenitor cells 
are present in the blood that reach the peritoneal cavity (Figueira, Abrão et al. 2011). 
Endometrial stem cells shed through fallopian tube during menstruation might be 
responsible for endometriotic implants. Also, this theory could account for the distant 
ectopic implants, as circulatory stem cells are able to reach peritoneal cavity as well as 
distant tissues and organs such as brain.  
Several experiments have demonstrated that endometrium-derived cells are capable of 
establishing endometriotic implants (Te Linde and Scott 1950; Ridley and Edwards 1958; 
D'Hooghe, Bambra et al. 1995). Xenografts of human endometrial tissue or dissociated 
endometrial cells have been used in immunocompromised mouse to investigate 
pathogenesis of endometriosis (Grümmer 2006; Masuda, Maruyama et al. 2007). This model 
provides an appropriate in vivo system to test the possible role of EnSCs in endometriosis. 
This is further supported by the demonstration of clonogenic cells in a long-term culture 
derived from a sample of endometriosis tissue (Tanaka, Nakajima et al. 2003). 
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The monoclonality of some endometrial lesions (Jimbo, Hitomi et al. 1997; Tamura, Fukaya 
et al. 1998; Wu, Basir et al. 2003) is consistent with the concept that endometriosis could 
have a stem cell origin. Furthermore, polyclonal endometriotic lesions may point to 
repeated seeding of the lesions with cells from other sources such as bone marrow or from 
establishment of different fragments of shed endometrium containing several stem cells. 
Although stem cell-based pathogenesis of endometriosis is not fully established the 
previous studies have demonstrated the role of unfractionated endometrial stem cells to 
ectopic endometrial growth (Sasson and Taylor 2008). Endometriosis was also generated 
experimentally by ectopic wild-type endometrial implantation in the peritoneal cavity of 
hysterectomized LacZ transgenic mice (Du and Taylor 2007). LacZ-expressing stem cells of 
extrauterine origin were incorporated into the endometriosis implants. These cells were able 
to differentiate into epithelial and stromal cells at a frequency of 0.04% and 0.1%, 
respectively (Du and Taylor 2007).  
In a study carried out by Leyendecker et al. expression pattern of estrogen receptor, two 
isoforms of progesterone receptor and P450 aromatase were compared on normal 
endometrium and ectopic endometriotic implants (Leyendecker, Herbertz et al. 2002). The 
expression pattern of the endometriotic implants was identical to that of basalis layer of 
eutopic endometrium and was out of phase with the functionalis layer. This study also 
demonstrated that more basalis layer was shed in women with endometriosis compared to 
the normal women. As basalis layer contain endometrial stem/progenitor cells and it is 
shed in larger extent in endometriosis that is in accordance with the larger volume of 
retrograde menstrual flow, this may suggest that endometriosis implants results from the 
retrograde menstruation of endometrial stem/progenitor cells. 
Additionally, it has been postulated that some forms of endometriosis may arise from 
remnants of fetal müllerian cells which have characteristics of stem cells such as 
multipotency and self-renewal.  
Thus, stem cell-based pathogenesis of endometriosis could be suggested and this theory 
could account for the observations that support the cellular origin of ectopic implants.  
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